Scrivo R, Castellani C, Mancuso S, Sciarra G, et al. Effectiveness of non-medical switch from adalimumab bio-originator to SB5 biosimilar and from ABP501 adalimumab biosimilar to SB5 biosimilar in patients with chronic inflammatory arthropathies: a monocentric observational study. Clin Exp Rheumatol 2023;41:613-619.
PMID: 35916302